By Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group Applied Clinical Trials – August 23, 2018 Although the pharmaceutical industry has always incorporated risk-based processes, the ICH E6 (R2) addendum now mandates that clinical trial operations also include risk-based approaches. Based on the latest research, and The Avoca Group’s experience helping companies […]
Read MoreAugust 13-14, 2018 | Philadelphia, PA
Attend a presentation entitled, “Comparing how agencies (FDA, EMA, MHRA, Health Canada, PMDA, and CFDA) conduct inspections. What are the implications of ICH E6 (R2), based on recent inspection experiences?"
July 25, 2018 | 11:00-12:00 EDT
Back by popular demand. Co-hosted by Steve Whittaker, Senior Consultant and Executive Director, The Avoca Group, and Grace Crawford, VP of Clinical Quality and Compliance, MedImmune.
By Ed Miseta, Chief Editor, Clinical Leader Clinical Leader – July 9, 2018 We all know the days of Big Pharma companies launching billion-dollar blockbuster drugs are generally behind us. Today, novel new therapies are harder to bring to market. Trials are costly, take a long time to complete, and too many of them […]
Read MoreJune 24-28, 2018 | Boston, MA
Attend a forum entitled, “Executives Respond to the State of the Industry Report on Risk Based Approaches in Clinical Trials: Opportunity or Threat?” led by Dennis Salotti, VP of Operations, The Avoca Group.
Press Release – June 13, 2018 Princeton, NJ. The Avoca Group announced today that it has launched the Diligent® Qualification Platform, the clinical research industry’s first centralized platform for vendor qualification as well as eLuminate™, an online […]
Read More13-14 June 2018 | Dublin, Ireland
Join your peers for two insightful days of high-quality analyses and discussions focused on transforming clinical trial execution. Avoca will also unveil two new technology platforms.
Press Release – June 6, 2018 Princeton, NJ. The Avoca Group announced today that Dr. Jeff Kasher has assumed the role of Executive Chair for the Avoca Quality Consortium (AQC), its member-based industry collaborative focused on driving efficiency, improving quality, and mitigating risk in clinical trial execution. The AQC is comprised of clinical operations, quality, […]
Read More